Other data acquired in early phase clinical studies

At the end of the study, the pharmacokinetic characteristics of the drug would be evaluated, and the systemic exposure for each dosage regimen compared with the intravenous route of administration. 

10 Other data acquired in early phase clinical studies 

As we saw in Section 7.5, one research c uestion of interest in early phase trials is  

More extensive discussion of these safety assessments is provided in the following chapters, but it is useful to introduce these topics at this point. 

There is a very wide range of clinical chemistry tests that can be conducted, including liver 

---